Immunotherapy & Immuno-Oncology
Part of Healthcare - Oncology
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 JNJ | Johnson & Johnson | $0.6t | $242.38 | -0.3% | 789.7K |
 ABBV | ABBVIE INC. | $377.0b | $207.43 | -0.7% | 816.3K |
 AZN | AstraZeneca PLC | $300.7b | $203.98 | +0.2% | 260.8K |
 MRK | Merck & Co., Inc. | $292.0b | $120.58 | -0.2% | 1.4M |
 AMGN | Amgen Inc | $188.1b | $344.50 | -1.0% | 574.6K |
 BMY | Bristol-Myers Squibb Co. | $122.0b | $59.04 | -0.9% | 1.2M |
 REGN | Regeneron Pharmaceuticals Inc | $79.2b | $763.78 | +0.3% | 95.7K |
 RPRX | Royalty Pharma plc Class A Ordinary Shares | $19.9b | $47.69 | -1.8% | 261.6K |
 MRNA | Moderna, Inc. Common Stock | $19.1b | $48.66 | -1.1% | 1.0M |
 IBRX | ImmunityBio, Inc. Common Stock | $6.8b | $7.30 | +0.1% | 4.8M |
 ACLX | Arcellx, Inc. Common Stock | $6.7b | $114.80 | +0.0% | 227.8K |
 CGON | CG Oncology, Inc. Common stock | $5.4b | $67.64 | +0.2% | 179.8K |
 RCUS | Arcus Biosciences, Inc. | $2.6b | $22.92 | -0.2% | 130.8K |
 SNDX | Syndax Pharmaceuticals, Inc. | $2.0b | $24.81 | -1.4% | 388.7K |
 NKTR | Nektar Therapeutics | $1.9b | $75.26 | -2.3% | 72.0K |
 IOVA | Iovance Biotherapeutics, Inc. Common Stock | $1.4b | $3.37 | -1.9% | 3.4M |
 IMTX | Immatics N.V. Ordinary Shares | $1.2b | $10.46 | +1.0% | 106.8K |
 BCAX | Bicara Therapeutics Inc. Common Stock | $1.2b | $21.29 | -0.9% | 76.7K |
 PGEN | Precigen, Inc. Common Stock | $1.2b | $4.13 | +4.7% | 1.2M |
 CRVS | Corvus Pharmaceuticals, Inc. | $1.1b | $15.31 | +4.2% | 223.6K |
 CTMX | CytomX Therapeutics, Inc. | $1.0b | $4.51 | -1.0% | 622.9K |
 CMPX | Compass Therapeutics, Inc. Common Stock | $0.9b | $5.58 | +2.3% | 476.0K |
 INBX | Inhibrx Biosciences, Inc. Common Stock | $0.9b | $65.38 | +2.9% | 41.0K |
 XNCR | Xencor, Inc. | $0.8b | $12.70 | -0.9% | 314.4K |
 CGEM | Cullinan Therapeutics, Inc. Common Stock | $0.8b | $15.22 | +5.5% | 505.0K |
 JANX | Janux Therapeutics, Inc. Common Stock | $0.8b | $14.99 | +1.0% | 214.1K |
 SLS | SELLAS Life Sciences Group, Inc. Common Stock | $0.7b | $4.63 | +12.2% | 2.9M |
 OMER | Omeros Corporation | $0.7b | $11.12 | +2.0% | 402.9K |
 REPL | Replimune Group, Inc. | $0.6b | $8.63 | +2.7% | 987.2K |
 CBIO | Crescent Biopharma, Inc. Common Stock | $0.5b | $19.93 | +2.8% | 80.4K |
 AURA | Aura Biosciences, Inc. Common Stock | $394.2m | $6.95 | +6.3% | 146.9K |
 CADL | Candel Therapeutics, Inc. Common Stock | $328.1m | $5.12 | +2.3% | 591.2K |
 GLSI | Greenwich LifeSciences, Inc. | $297.7m | $22.93 | +0.5% | 35.3K |
 ALXO | ALX Oncology Holdings Inc. Common Stock | $251.4m | $1.99 | +0.8% | 139.2K |
 CHRS | Coherus Oncology, Inc. Common Stock | $239.8m | $1.75 | +1.4% | 210.8K |
 CNTX | Context Therapeutics Inc. Common Stock | $225.1m | $2.80 | +2.9% | 156.3K |
 CGEN | Compugen Ltd | $188.2m | $2.23 | -1.4% | 161.8K |
 ELTX | Elicio Therapeutics, Inc. Common Stock | $185.4m | $11.27 | +5.8% | 34.8K |
 MGNX | MacroGenics, Inc. | $175.4m | $3.22 | +5.0% | 468.3K |
 AGEN | Agenus Inc. | $124.4m | $3.94 | +18.2% | 946.2K |
 GNLX | Genelux Corporation Common Stock | $103.1m | $2.69 | +4.9% | 121.8K |
 HURA | TuHURA Biosciences, Inc. Common Stock | $97.7m | $1.38 | -2.1% | 546.7K |
 ONCY | Oncolytics Biotech, Inc. Common Shares | $86.6m | $0.97 | +0.7% | 236.0K |
 ANIX | Anixa Biosciences, Inc. | $83.8m | $2.61 | +2.2% | 19.8K |
 MAIA | MAIA Biotechnology, Inc. | $79.5m | $1.29 | -2.6% | 207.4K |
 XBIT | XBiotech Inc | $69.2m | $2.37 | +1.0% | 5.4K |
 BYSI | BeyondSpring Inc. Ordinary Shares | $66.6m | $1.72 | -0.1% | 430 |
 IBO | Impact BioMedical, Inc. | $63.1m | $0.62 | +4.5% | 88.5K |
 TIL | Instil Bio, Inc. Common Stock | $54.1m | $7.88 | -1.9% | 27.2K |
 XLO | Xilio Therapeutics, Inc. Common Stock | $47.6m | $8.67 | +1.8% | 5.8K |